{
    "filename": "Green Tea -  Potential Health Benefits.pdf",
    "type": "pdf",
    "title": null,
    "authors": null,
    "lastmodifiedtime": "D:20090324144108-05'00'",
    "text": "April 1, 2009  \u25c6 Volume 79, Number 7 \t www.aafp.org/afp \t American Family Physician \u2002 591Green Tea: Potential Health Benefits\nCRAIG \t SCHNEIDER, \t MD, \tMaine Medical Center, Portland, Maine\nTIFFANY\n\t\nSEGRE,\n\t\nMD,\n\tGorham Family Medicine, Gorham, Maine\n\tTea\tis \t the \t most \t frequently \t con-\nsumed\n\t\nbeverage\n\t\nin\n\t\nthe\n\t\nworld\n\t\nafter\n\t\nwater,\n\t\nand\n\t\nthe\n\t\nfourth\n\t\nmost\n\t\nfrequently\n\t\nconsumed\n\t\nbeverage\n\t\nin\n\t\nthe\n\t\nUnited\n\t\nStates.\n\t\nThe\n\t\naverage\n\t\nAmerican\n\t\ndrinks\n\t\n155\n\t\ncups\n\t\nof\n\t\ntea\n\t\nannually,1\tand \t green \t \ntea\n\t\nextracts\n\t\nare\n\t\na\n\t\nrapidly\n\t\ngrowing\n\t\ndietary\n\t\nsupplement\n\t\nin\n\t\nthe\n\t\nUnited\n\t\nStates.\n\t\nLegend\n\t\nhas\n\t\nit\n\t\nthat\n\t\ndrinking\n\t\ntea\n\t\noriginated\n\t\nwhen\n\t\nleaves\n\t\nfrom\n\t\na\n\t\nnearby\n\tCamellia sinen -\nsis plant \t landed \t in \t a \t Chinese \t emperor\u2019s \t \npot\n\t\nof\n\t\nboiling\n\t\nwater.2\tGreen \t tea \t is \t made \t by \t \nlightly\n\t\nsteaming\n\t\nand\n\t\ndrying\n\t\nthe\n\t\nleaves\n\t\nfrom\n\t\t\nC. sinensis . \t Green \t tea, \t black \t tea, \t and \t oolong \t \ntea\n\t\nare\n\t\nall\n\t\ndistinct\n\t\npreparations\n\t\nof\n\t\nthis\n\t\nplant.\nPharmacology\nMultiple\n\t\nsubstances\n\t\nin\n\t\ngreen\n\t\ntea\n\t\nmay\n\t\ncontrib -\nute\n\t\nto\n\t\nits\n\t\nhealth\n\t\nbenefits.\n\t\nCaffeine,\n\t\ntheanine,\n\t\ntheaflavins,\n\t\ntheobromine,\n\t\ntheophylline,\n\t\nand\n\t\t\nphenolic\n\t\nacids\n\t\nare\n\t\nfound\n\t\nin\n\t\ngreen\n\t\ntea.3\tIn\t\nvitro,\n\t\nanimal,\n\t\nand\n\t\nhuman\n\t\nstudies\n\t\nsuggest\n\t\nthat\n\t\nthe\n\t\npolyphenols\n\t\nin\n\t\ngreen\n\t\ntea\n\t\nare\n\t\npotent\n\t\nantioxidants\n\t\nwith\n\t\nantimutagenic,\n\t\nantidia -\nbetic,\n\t\nantibacterial,\n\t\nanti-inflammatory,\n\t\nand\n\t\nhypocholesterolemic\n\t\nproperties.3\tGreen \t tea \t \nis\n\t\n20\n\t\nto\n\t\n45\n\t\npercent\n\t\npolyphenols\n\t\nby\n\t\nweight,\n\t\nof\n\t\nwhich\n\t\n60\n\t\nto\n\t\n80\n\t\npercent\n\t\nare\n\t\ncatechins.\n\t\nGreen\n\t\ntea\n\t\ncontains\n\t\nmore\n\t\ncatechins\n\t\nthan\n\t\noolong\n\t\nor\n\t\nblack\n\t\ntea,3\talthough \t catechin \t content \t may \t \nvary\n\t\nbecause\n\t\nof\n\t\nprocessing\n\t\nand\n\t\ngrowing\n\t\ncon-\nditions.\n\t\nEpigallocatechin\n\t\ngallate\n\t\n(EGCG)\n\t\nis\n\t\nthe\n\t\nmost\n\t\nprevalent\n\t\ncatechin\n\t\nin\n\t\ntea,\n\t\nand\n\t\nthe\n\t\nmost\n\t\nresearched.Uses\n\u2002\nand\n\u2002\nEffectiveness\nGreen\n\t\ntea\n\t\npolyphenols\n\t\nmay\n\t\nplay\n\t\na\n\t\nbeneficial\n\t\nrole\n\t\nin\n\t\nseveral\n\t\nconditions.\n\t\nThey\n\t\nare\n\t\nmost\n\t\ncommonly\n\t\nstudied\n\t\nin\n\t\ngenital\n\t\nwarts,\n\t\ncancer,\n\t\nweight\n\t\nmanagement,\n\t\nand\n\t\ncardiovascular\n\t\ndisease.\n\t\nThe\n\t\nresults\n\t\nfrom\n\t\nepidemiologic\n\t\nand\n\t\nclinical\n\t\nstudies\n\t\nare\n\t\nmixed.3\nGEnital \u2002 and \u2002 P E rianal \u2002 Warts\nThe\t U.S. \t Food \t and \t Drug \t Administration \t has \t \napproved\n\t\na\n\t\ntopical\n\t\nointment\n\t\n(sinecatechins\n\t\n15%\n\t\n[Veregen])\n\t\nfor\n\t\nthe\n\t\ntreatment\n\t\nof\n\t\nexternal\n\t\ngenital\n\t\nand\n\t\nperianal\n\t\nwarts\n\t\ncaused\n\t\nby\n\t\nhuman\n\t\npapillomavirus\n\t\n(HPV).\n\t\nThe\n\t\nactive\n\t\ningredient\n\t\nis\n\t\na\n\t\ndefined\n\t\nmixture\n\t\nof\n\t\ncatechins\n\t\nextracted\n\t\nfrom\n\t\ngreen\n\t\ntea\n\t\nthat\n\t\nacts\n\t\nas\n\t\nan\n\t\nimmunomod -\nulator\n\t\nand\n\t\ninhibits\n\t\nmajor\n\t\nviral\n\t\nfunctions.4,5 \nPreliminary\n\t\ntrials\n\t\nalso\n\t\nsuggest\n\t\na\n\t\npossible\n\t\nrole\n\t\nfor\n\t\nsinecatechins,\n\t\nalone\n\t\nor\n\t\nin\n\t\ncombina -\ntion\n\t\nwith\n\t\nan\n\t\noral\n\t\nextract,\n\t\nin\n\t\ntreating\n\t\ncervical\n\t\nlesions\n\t\ncaused\n\t\nby\n\t\nHPV.6\nCan CE r\nMany \t studies \t suggest \t an \t inverse \t relation -\nship\n\t\nbetween\n\t\ngreen\n\t\ntea\n\t\nintake\n\t\nand\n\t\nthe\n\t\nrisk\n\t\nof\n\t\na\n\t\nvariety\n\t\nof\n\t\ncancers,\n\t\nalthough\n\t\nother\n\t\nstudies\n\t\nhave\n\t\nfound\n\t\nno\n\t\nassociation.7\tClinical \t trials \t \nhave\n\t\nbeen\n\t\nsmall\n\t\nand\n\t\nheterogenous\n\t\nwith\n\t\ncon-\ntradictory\n\t\nresults.\n\t\nDietary,\n\t\nenvironmental,\n\t\nand\n\t\npopulation\n\t\ndifferences\n\t\nmay\n\t\naccount\n\t\nfor\n\t\nthese\n\t\ninconsistencies.\nA\n\t\n2006\n\t\nmeta-analysis\n\t\nof\n\t\nepidemiologic\n\t\nstudies\n\t\nfound\n\t\nthat\n\t\nhigh\n\t\nintake\n\t\nof\n\t\ngreen\n\t\ntea\n\t\nwas\n\t\nassociated\n\t\nwith\n\t\na\n\t\n20\n\t\npercent\n\t\nreduction\n\tGreen tea has been used widely and in high doses for centuries as a health tonic in many societ -\nies. Evidence suggests that green tea is effective for treating genital warts. There is some sup -\nportive evidence for the use of green tea in cancer prevention. Drinking green tea is associated \nwith a decrease in all-cause mortality, but not in cancer-related mortality. Small clinical studies \nhave found that green tea may also be helpful in losing and managing weight, and lowering cho -\nlesterol. Epidemiologic evidence suggests that green tea may prevent stroke and cardiovascular \ndisease. Green tea appears to be safe, although there have been case reports of hepatotoxicity \npossibly related to a specific extract in pill or beverage form. Green tea seems to be a low-risk \ncomplementary therapy for a number of conditions, but more studies are needed. (Am Fam \nPhysician.  2009;79(7):591-594. Copyright \u00a9 2009 American Academy of Family Physicians.)Com P l E m E ntary \u2002 and \u2002\u2002\nalt\nE\nrnativ\nE\u2002\nm\nE\ndi\nC\nin\nE\nDownloaded from the American Family Physician Web site at www.aafp.org/afp. Copyright \u00a9 2009 American Academy of Family Physicians. For the private, noncommercial\n                    use of one individual user of the Web site. All other rights reserved. Contact copyrights@aafp.org for copyright questions and/or permission requests.592\u2002 American Family Physician  www.aafp.org/afp \t Volume 79, Number 7  \u25c6 April 1, 2009in\tthe\t risk\t of\tbreast\t cancer\t (odds\t ratio\t [OR]\t =\t0.78;\t\n95%\t confidence\t interval\t [CI],\t 0.61\t to\t0.98).8\tThe\t stron -\ngest\t association\t was\t in\tthe\tU.S.\t Asian\t population.\t Large\t\nJapanese\t cohort\t studies\t did\t not\t reveal\t a\treduction\t in\t\nbreast\t cancer\t diagnoses\t with\t green\t tea\tintake,\t although\t\nthe\tstudies\t were\t confounded\t by\tpervasive\t green\t tea\tcon-\nsumption\t among\t participants\t (i.e.,\t 98\tpercent\t of\tJapa-\nnese\tadults\tdrink\tgreen\ttea).8\nA\tsecond \tmeta-analysis \tby\tthe\tsame \tauthors \tfound\t\nthat\thigh \tconsumption \tof\tgreen \ttea\twas\tassociated\t\nwith \tan\t18\tpercent \treduction \tin\tthe\trisk\tof\tcolorectal\t\ncancer \t(summary \tOR\t=\t0.82; \t95% \tCI,\t0.69\tto\t0.98).9\t\nAnother \tlarge \tprospective \tcohort \tstudy \tof\tmore \tthan\t\n40,000 \tJapanese \tadults \tfound \tthat\tgreen \ttea\tbeverage\t\nconsumption \twas\tinversely \tassociated \twith \tall-cause\t\nmortality \tat\t11\tyears, \tbut\tnot\tspecifically \twith \tcancer-\nrelated \tmortality.10\nSome\t data\t are\tavailable\t on\tgreen\t tea\tand\t its\teffect\t on\t\nstomach\t and\t esophageal\t cancers.\t One\t Chinese\t study\t\nof\tmore\t than\t 18,000\t men\t found\t that\t those\t who\t drank\t\ngreen\t tea\twere\t about\t one\t half\t as\tlikely\t to\tdevelop\t stom -\nach\tor\tesophageal\t cancer\t as\tmen\t who\t drank\t little\t tea.11\t\nThe\t authors\t reported\t an\tinverse\t relationship\t between\t\nEGCG\t intake\t and\t the\trisk\t of\tgastric\t cancer,\t or\tgastric\t\nand\t esophageal\t cancers\t combined\t (OR\t =\t0.52;\t 95%\t CI,\t\n0.28\tto\t0.97,\tand\tOR\t=\t0.58;\t95%\tCI,\t0.34\tto\t0.90).11\nOther\t studies\t have\t examined\t the\trelationship\t between\t\ngreen\t tea\tand\t prostate\t cancer.\t A\tsmall\t controlled\t trial\t\nfollowed\t 60\tpatients\t with\t high-grade\t prostate\t intraepi -\nthelial\t neoplasia.12\tPatients\t were\t grouped\t randomly\t to\t\nreceive\t green\t tea\tcatechins\t extract\t (200\t mg\tthree\t times\t\na\tday)\t or\tplacebo\t for\tone\tyear.12\tNine\t cancers\t were\t found\t\nin\tthe\t placebo\t group,\t whereas\t only\t one\t cancer\t was\t\ndetected\t in\tthe\tgreen\t tea\tgroup.12\tAnother\t small\t clinical\t\ntrial\t found\t no\tbenefit\t from\t the\tuse\tof\tgreen\t tea\textract\t\n(500\t mg\tper\tday\t for\ttwo\t to\tfour\t months)13;\thowever,\t a\t\nrecent\t epidemiologic\t study\t of\tnearly\t 50,000\t Japanese\t\nmen\t found\t a\tdose-dependent\t relationship\t between\t green\t\ntea\tconsumption\t and\t a\treduction\t in\tthe\trisk\t of\tadvanced\t\nprostate\tcancer.14WEiGht\u2002mana GEmEnt\nSeveral\t small\t clinical\t trials\t have\t investigated\t the\teffect\t\nof\tgreen\t tea\ton\tweight\t loss\t and\t weight\t management.15,16 \nSome\t controlled\t trials\t suggest\t a\tbenefit\t from\t green\t tea,\t\nwhereas\t others\t do\tnot.\t None\t of\tthe\tstudies\t demonstrate\t\npersistent\teffects.\nIn\tone\t randomized\t placebo-controlled\t double-blind\t\ntrial,\t investigators\t tracked\t the\t effects\t of\tgreen\t tea\tin\t\t\n76\tmen\t and\t women\t who\t were\t overweight\t or\tobese.17\tThe\t\neffects\t of\ta\tgreen\t tea/caffeine\t mixture\t (two\t capsules,\t each\t\ncontaining\t 45\tmg\tof\tEGCG\t and\t 25\tmg\tof\tcaffeine,\t taken\t\nbefore\t meals)\t on\tpersons\t who\t habitually\t consumed\t large\t\namounts\t of\tcaffeine\t (more\t than\t 300\t mg\tper\tday)\t were\t\ncompared\t with\t the\teffects\t on\tthose\t who\t consumed\t small\t\namounts\t of\tcaffeine.\t There\t appeared\t to\tbe\tno\teffect\t on\t\nthe\thigh\t consumers,\t but\tthe\tlow\tconsumers\t regained\t sig-\nnificantly\t less\tweight\t (P\t<\t.01)\t than\t participants\t receiv -\ning\tplacebo.17\nA\t12-week\t double-blind\t controlled\t trial\t compared\t the\t\neffects\t of\ta\tgreen\t tea\textract\t beverage\t high\t in\tcatechins\t\nwith\t a\tlower\t catechin\t placebo\t beverage\t in\t240\t Japanese\t\nadults\t who\t were\t obese.18\tThe\t results\t showed\t that\t the\t\nactive\t treatment\t group\t had\t greater\t reductions\t in\tbody\t\nweight,\t body\t mass\t index,\t body\t fat\tratio,\t body\t fat\tmass,\t\nand\twaist\tand\thip\tcircumference\t( P\t<\t.05).18\nCardiovas CUlar\u2002F UnCtion\nEpidemiologic\t studies\t suggest\t that\t green\t tea\tintake\t is\t\nassociated\t with\t a\treduced\t risk\t of\tcardiovascular\t disease,\t\nbut\t the\tmechanisms\t remain\t uncertain.\t Clinical\t trials\t\nshow\t inconsistent\t results\t in\tthe\teffect\t of\tgreen\t tea\ton\t\nlipid\tlevels,\tblood\tpressure,\tand\tcoronary\tartery\tdisease.\nA\tprospective \tcohort \tstudy \tof\tmore \tthan \t40,000\t\nJapanese \tadults \tfound \tthat\tgreen \ttea\tconsumption \twas\t\ninversely \tassociated \twith \tcardiovascular \tdisease \tmor-\ntality.10\tWomen \twho \tconsumed \tfive\tor\tmore \tcups \tper\t\nday\thad\ta\t31\tpercent \tlower \trisk\tof\tdying \tfrom \tcardio -\nvascular \tdisease.10\tParticipants \twho \tconsumed \tfive\tor\t\nmore \tcups \tper\tday\thad\ta\tsignificantly \treduced \tincidence\t\nof\tstroke.10sort :\u2002KEy\u2002rEComm Endations\u2002F or\u2002P raCtiCE\nClinical recommendationEvidence \nrating References\nOintment derived from green tea appears to be effective in the treatment of genital warts. B 4, 5\nDrinking green tea may help prevent cancer of the breast, gastrointestinal tract, and prostate, but results \nare mixed.B 8, 9, 11, 12, 14\nGreen tea beverages may be effective for short-term weight loss, although studies are inconsistent. B 17, 18\nDrinking green tea is associated with decreased risk of stroke and cardiovascular disease, although the \nevidence is conflicting.B 10\nA = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-\noriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, go to http://www.aafp.\norg/afpsort.xml.April 1, 2009  \u25c6 Volume 79, Number 7 \t www.aafp.org/afp \t American Family Physician \u2002 593A\tcross-sectional\t study\t of\tnearly\t 1,000\t Japanese\t adults\t\nin\ttheir\t 40s\t found\t no\tassociation\t between\t green\t tea\t\nintake\t and\t total\t cholesterol\t level.19\tHowever,\t a\tdouble-\nblind\t randomized\t placebo-controlled\t trial\t of\t240\t Chi-\nnese\t adults\t with\t mild\t to\tmoderate\t hypercholesterolemia\t\n(low-density\t lipoprotein\t [LDL]\t cholesterol\t =\t130\t to\t\t\n190\tmg\tper\tdL\t[3.36\t to\t4.91\t mmol\t per\tL])\twho\t received\t a\t\nonce-daily\t theaflavin-enriched\t green\t tea\textract\t reduced\t\ntheir\t LDL\t by\t16.4\t percent\t \u00b1\t1.1\tpercent\t (P\t<\t.01)\t and\t\ntheir\t total\t cholesterol\t by\t11.3\t percent\t \u00b1\t0.9\tpercent\t com -\npared\t with\t placebo.20\tParticipants\u2019\t high-density\t lipopro -\ntein\t cholesterol\t and\t triglyceride\t measurements\t were\t not\t\nchanged\tsignificantly.20\ndosing, \u2002adverse \u2002Effects, \u2002interactions,\u2002 \u2002\nand\u2002Contraindications\nGreen\t tea\tis\tavailable\t in\tvarious\t formulations.\t Typical\t\nconsumption\t is\tabout\t three\t cups\t per\tday\t(1\tteaspoon\t of\t\ntea\tleaves\t in\t8\toz\tof\tboiling\t water),\t which\t provides\t 240\tto\t\n320\tmg\tof\tpolyphenols.\t Green\t tea\tin\textract\t form\t should\t\nbe\ttaken\t in\trecommended\t doses\t and\t with\t a\tmeal.\t The\t\ncost\t of\tgreen\t tea\tvaries\t by\tquality,\t type,\t and\t preparation\t\n(Table 1) .\nGreen\t tea\tis\tsafe\t for\tmost\t adults\t when\t used\t in\tmod -\nerate\t quantities.\t The\t most\t common\t adverse\t effects\t of\t\tconsuming\t green\t tea\torally\t are\tgastrointestinal\t upset\t\nand\t central\t nervous\t system\t stimulation\t from\t caffeine\t\ncontent\t (Table 2 4-21).\tThere\t are\tseveral\t case\t reports\t of\t\nhepatotoxicity\t linked\t to\tgreen\t tea\textract\t products\t in\tpill\t\nor\tbeverage\t form.\t The\t mechanism\t for\tthis\t is\tunknown.21\t\nAllergic\t reactions\t have\t been\t reported\t with\t topical\t green\t\ntea\tointment,\t which\t may\t cause\t cervical\t and\t vaginal\t\ninflammation,\tirritation,\tand\tvulvar\tburning.6\nGreen\t tea\tcontains\t a\tsmall\t amount\t of\tvitamin\t K.\tThere\t\nare\tconflicting\t reports\t about\t whether\t green\t tea\tinterferes\t\nwith\t anticoagulant\t or\tantiplatelet\t medications.\t In\tone\t\ncase\t report,\t large\t amounts\t of\tgreen\t tea\t(0.5\t to\t1.0\tgallon)\t\nantagonized\tthe\teffects\tof\twarfarin\t(Coumadin).22\nBecause\t catechins\t seem\t to\tinhibit\t dihydrofolate\t reduc -\ntase,\t there\t is\tconcern\t that\t consuming\t large\t amounts\t of\t\ngreen\t tea\tmight\t cause\t antifolate\t activity,\t which\t could\t\npotentially\t increase\t the\trisk\t of\tbirth\t defects\t related\t to\t\nfolic\tacid\tdeficiency.23\nBottom \u2002line\nThe\tNational \tCancer \tInstitute \tis\tactively \texploring \ttea\t\ncompounds \tas\tcancer-chemopreventive \tand\tadjuvant-\ntreatment \tagents \tin\thuman \ttrials. \tAlthough \tfurther \tstudies\t\nare\tneeded, \tgreen \ttea\tappears \tto\tbe\ta\tlow-risk, \tinexpensive\t\ncomplementary \ttherapy \tfor\ta\tnumber \tof\tconditions.table\u20021.\u2002Commonly \u2002studied \u2002dosages \u2002and\u2002Formulations \u2002of\u2002Green \u2002tea\nUse* Formulation Dosage \u2020 Cost \u2021\nTreatment of external genital and \nperianal warts caused by human \npapillomavirusSinecatechins \n15% ointment \n(Veregen)0.5 cm per wart three times per day \nfor 16 weeks15-g tube ranges from $250 to \n$300\nReduction of breast cancer risk Green tea beverage Three or more cups per day Green tea ranges from $5 for 30 \ntea bags to $23 for 240 tea bags; \nloose green tea leaves range \nfrom $7 to $45 for 75 servings of \naverage to good quality tea\nReduction of colorectal cancer risk Green tea beverage Five to 10 cups per day \u2014\nWeight reduction and \nmanagementCapsules or \nbeverageTwo capsules three times a day \nbefore meals (45 mg of EGCG plus \n25 mg of caffeine per capsule)\n340 mL (one cup) of green tea \ncontaining 600 mg of catechins \nand 70 mg of caffeine Extracts with 45 mg EGCG and  \n25 mg caffeine are roughly $5 to \n$10 for 100 capsules\n\u2014\nReduction of cholesterol Theaflavin-enriched \ngreen tea extract \n(Teaflavin)375-mg capsule daily (75 mg of \ntheaflavins, 150 mg of green tea \ncatechins, and 150 mg of other \ntea polyphenols)30-day supply ranges from  \n$18 to $25\n Green tea beverage 10 or more cups per day \u2014\nReduction of cardiovascular risk Green tea beverage Five or more cups per day \u2014\nEGCG = epigallocatechin gallate.\n*\u2014Independent testing of green tea dietary supplements is available at http://www.consumerlab.com.\n\u2020\u2014More condition-specific dosing recommendations are available at National Medicines Comprehensive Database (http://www.naturaldatabase.\ncom) and National Standard (http://www.naturalstandard.com).\n\u2021\u2014These costs are estimates based on a search of commonly used Internet sites (http://www.amazon.com, http://www.inpursuitoftea.com,  \nhttp://www.naturesstore.com, http://www.vitacost.com, and http://www.vitaminshoppe.com).594\u2002 American Family Physician  www.aafp.org/afp \t Volume 79, Number 7  \u25c6 April 1, 2009Members of various family medicine departments develop articles for \n\u201cComplementary and Alternative Medicine.\u201d This is one in a series \ncoordinated by Sumi Sexton, MD, and Benjamin Kligler, MD, MPH.\nthe\u2002a uthors\nCRAIG SCHNEIDER, MD, is director of integrative medicine in the Depart -\nment of Family Medicine at Maine Medical Center in Portland. He received \nhis medical degree from the Columbia University College of Physicians and \nSurgeons in New York, NY. Dr. Schneider completed a family medicine resi -\ndency at Maine Medical Center and a fellowship in integrative medicine at \nthe University of Arizona in Tucson.\nTIFFANY SEGRE, MD, practices family and integrative medicine in Gorham, \nMaine. At the time the article was written, Dr. Segre was completing a \nfellowship through the combined integrative medicine program at Maine \nMedical Center and the University of Arizona in Tucson. She received her \nmedical degree from the Temple University School of Medicine in Philadel -\nphia (Pa.). She completed a family medicine residency at Maine Medical \nCenter in Portland.\nAddress correspondence to Craig Schneider, MD, Maine Medical Cen -\nter, 22 Bramhall St., Portland, ME 04102. Reprints are not available \nfrom the authors.\nAuthor disclosure: Nothing to disclose.\nrEFErEnCEs\n 1. Schardt D. Does tea ward off disease? Nutr Action Healthletter . 2007;  \n34(2):9-11.\n 2. Patel SH. Camellia sinensis : historical perspectives and future prospects. \nJ Agromedicine . 2005;10(2):57-64. 3. Cabrera C, Artacho R, Gim\u00e9nez R. Beneficial effects of green tea\u2014  \na review. J Am Coll Nutr . 2006;25(2):79-99.\n 4. Gross G, et al. A randomized, double-blind, four-arm parallel-group, \nplacebo-controlled Phase II/III study to investigate the clinical effi -\ncacy of two galenic formulations of Polyphenon E in the treatment \nof external genital warts. J Eur Acad Dermatol Venereol . 2007;21(10):  \n1404-1412.\n 5. U.S. Food and Drug Administration. Veregen (Kunecatechins) ointment, \n15%. http://www.fda.gov/cder/foi/label/2006/021902lbl.pdf. Accessed \nDecember 22, 2008.\n 6. Ahn WS, Yoo J, Huh SW, et al. Protective effects of green tea extracts \n(polyphenon E and EGCG) on human cervical lesions. Eur J Cancer Prev . \n2003;12(5):383-390.\n 7. Bushman JL. Green tea and cancer in humans: a review of the literature. \nNutr Cancer . 1998;31(3):151-159.\n 8. Sun CL, Yuan JM, Koh WP, Yu MC. Green tea, black tea and breast \ncancer risk: a meta-analysis of epidemiological studies. Carcinogenesis . \n2006;27(7):1310-1315.\n 9. Sun CL, Yuan JM, Koh WP, Yu MC. Green tea, black tea and colorectal \ncancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis . \n2006;27(7):1301-1309.\n 10. Kuriyama S, Shimazu T, Ohmori K, et al. Green tea consumption and \nmortality due to cardiovascular disease, cancer, and all causes in Japan: \nthe Ohsaki study. JAMA . 2006;296(10):1255-1265.\n 11. Sun CL, Yuan JM, Lee MJ, et al. Urinary tea polyphenols in relation to \ngastric and esophageal cancers: a prospective study of men in Shang -\nhai, China. Carcinogenesis . 2002;23(9):1497-1503.\n 12. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Che -\nmoprevention of human prostate cancer by oral administration of green \ntea catechins in volunteers with high-grade prostate intraepithelial neo -\nplasia: a preliminary report from a one-year proof-of-principle study. \nCancer Res . 2006;66(2):1234-1240.\n 13. Choan E, Segal R, Jonker D, et al. A prospective clinical trial of green tea \nfor hormone refractory prostate cancer: an evaluation of the complemen -\ntary/alternative therapy approach. Urol Oncol . 2005;23(2):108-113.\n 14. Kurahashi N, Sasazuki S, Iwasaki M, Inoue M, Tsugane S, for the \nJPHC Study Group. Green tea consumption and prostate cancer risk \nin Japanese men: a prospective study. Am J Epidemiol.  2008;167(1):  \n71-77.\n 15. Kovacs EM, Lejeune MP, Nijs I, Westerterp-Plantenga MS. Effects of \ngreen tea on weight maintenance after body-weight loss. Br J Nutr . \n2004;91(3):431-437.\n 16. Diepvens K, Kovacs EM, Vogels N, Westerterp-Plantenga MS. Meta -\nbolic effects of green tea and of phases of weight loss. Physiol Behav . \n2006;87(1):185-191.\n 17. Westerterp-Plantenga MS, Lejeune MP, Kovacs EM. Body weight loss \nand weight maintenance in relation to habitual caffeine intake and \ngreen tea supplementation. Obes Res . 2005;13(7):1195-1204.\n 18. Nagao T, Hase T, Tokimitsu I. A green tea extract high in catechins \nreduces body fat and cardiovascular risks in humans. Obesity (Silver \nSpring) . 2007;15(6):1473-1483.\n 19. Tsubono Y, Tsugane S. Green tea intake in relation to serum lipid \nlevels in Middle-aged Japanese men and women. Ann Epidemiol . \n1997;7(4):280-284.\n 20. Maron DJ, Lu GP, Cai NS, et al. Cholesterol-lowering effect of a theafla -\nvin-enriched green tea extract: a randomized controlled trial. Arch \nIntern Med . 2003;163(12):1448-1453.\n 21. Gloro R, Hourmand-Ollivier I, Mosquet B, et al. Fulminant hepatitis dur -\ning self-medication with hydroalcoholic extract of green tea. Eur J Gas -\ntroenterol Hepatol . 2005;17(10):1135-1137.\n 22. Taylor JR, Wilt VM. Probable antagonism of warfarin by green tea. Ann \nPharmacother . 1999;33(4):426-428.\n 23. Navarro-Per\u00e1n E, Cabezas-Herrera J, Garc\u00eda-C\u00e1novas F, Durrant MC, \nThorneley RN, Rodr\u00edguez-L\u00f3pez JN. The antifolate activity of tea cat -\nechins. Cancer Res . 2005;65(6):2059-2064.table\u20022.\u2002Key\u2002Points \u2002about \u2002Green \u2002tea\nEffectiveness\nEffective for treatment of genital warts4,5\nConflicting evidence for prevention and treatment of cancer 7-14\nConflicting evidence for weight loss15-18\nPossibly effective for prevention of stroke10\nConflicting evidence for decreasing risk of cardiovascular \ndisease10,19,20\nadverse\u2002effects\nCentral nervous system stimulation; gastrointestinal upset; case \nreports of hepatotoxicity involving green tea extract in pill or \nbeverage form21\nTopical ointment may cause local irritation6\ninteractions\nAdditive effect with stimulants (caffeine component)\ndosage\nAvailable as tea, liquid and solid extracts, and ointment\nCost\nPrices vary widely for tea and extracts by brand and quality, \nbut potentially as low as $5 to $18 for one-month supply; \nointment pricing varies by pharmacy, currently in $250 range \nor higher for 15-g tube\nBottom\u2002line\nSafe alternative to treat genital warts; inconsistent evidence for \nuse in cancer prevention, cardiovascular disease and stroke \nprevention, and weight management\nInformation from references 4 through 21."
}